Option Care Health, Inc. (NASDAQ:OPCH) Shares Bought by Algert Global LLC

Algert Global LLC grew its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 29.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 248,142 shares of the company's stock after acquiring an additional 56,235 shares during the period. Algert Global LLC owned about 0.15% of Option Care Health worth $5,757,000 as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in OPCH. Alyeska Investment Group L.P. boosted its stake in shares of Option Care Health by 159.0% in the fourth quarter. Alyeska Investment Group L.P. now owns 732,948 shares of the company's stock valued at $17,004,000 after purchasing an additional 450,000 shares during the period. Freestone Grove Partners LP purchased a new position in Option Care Health in the 4th quarter valued at approximately $17,487,000. Comerica Bank grew its stake in shares of Option Care Health by 13.1% in the fourth quarter. Comerica Bank now owns 1,357,628 shares of the company's stock worth $31,497,000 after acquiring an additional 157,198 shares in the last quarter. Schonfeld Strategic Advisors LLC purchased a new stake in shares of Option Care Health during the fourth quarter worth $533,000. Finally, Northern Trust Corp raised its stake in shares of Option Care Health by 11.8% in the fourth quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock valued at $60,934,000 after acquiring an additional 278,158 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.64% of the stock is currently owned by insiders.

Option Care Health Stock Performance

Shares of OPCH stock traded up $0.14 during trading hours on Friday, hitting $31.84. The stock had a trading volume of 1,566,842 shares, compared to its average volume of 1,840,162. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm has a market capitalization of $5.21 billion, a PE ratio of 26.76, a PEG ratio of 2.30 and a beta of 0.76. The stock's 50 day moving average is $33.24 and its 200 day moving average is $28.90. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. Option Care Health's quarterly revenue was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.26 EPS. As a group, research analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have weighed in on OPCH shares. JMP Securities restated a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a report on Tuesday, April 22nd. Barrington Research reiterated an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research note on Wednesday, April 30th. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price objective for the company from $26.00 to $33.00 in a report on Monday, January 13th. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and boosted their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. Finally, UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.